Clinical education for our referring partners is a core value at Colorado Retina Associates. We provide continuing education opportunities in partnership with Association of Regulatory Boards of Optometry (ARBO), Colorado Optometric Association (COA), Medical Education Resources (MER), Colorado Society of Eye Physicians and Surgeons, Denver Metro Optometric Society (DMOS), Colorado Medical Society, and the Join Commission on Allied Health Personnel in Ophthalmology (JCAHPO). Continuing education credits can be acquired via independent and sponsored lectures, or one-on-one opportunities shadowing our physicians in clinic. If you are interested in retina-focused CE please check the calendar for upcoming events, or book a CE/CME/ JCAHPO event for your office staff, fill out one of the contact boxes below to schedule with our marketing team.
We offer a variety of BENEFITS for our referring colleagues including:
Fill out the form to request 1-2 Colorado Retina physicians to provide your doctors or supporting staff with an in-person or virtual accredited CE, CME or JCAHPO retina-based course. If you have a recommendation for subject matter you’d like to learn more about, we encourage you to let us know.
We are always eager to put names to faces! If you are available, we would appreciate the opportunity to meet in a nonclinical setting. We want you to be able to refer with confidence to CRA, so let’s take some time to get to know one another, whether that be over lunch, dinner or happy hour – and it’s on us!
2021 will be Colorado Retina's 11th Annual Mile High Masters of Retina event, an educational meeting held in Denver, Colorado, geared toward primary eye care providers. This is a FREE event which offers COPE CE/CME to all licensed optometrists, ophthalmologists, registered nurses, and primary care physicians in attendance. The course will be taught by our retina specialists of Colorado Retina Associates, a fourteen physician owned and led, vitreoretinal practice serving the Colorado Rocky Mountain region.
The program will include lectures on a variety of retina and uveitis topics and complex cases. Attendees will learn about the best and most innovative diagnostic and treatment approaches in retinal surgery and care, as well as the optimal timing of referrals. The format is a half-day program beginning in at 7:30am and ending at 12:30pm on Sunday, February 28th 2021 *new date*.
Complimentary breakfast, snacks and parking are included. Onsite hotel rooms at the Denver Marriott Tech Center will available for reservation to attendees coming from out of town.
Upon conclusion of this activity, participants will be able to evaluate current approaches to the diagnosis and management of common retinal conditions. Review when and how quickly to refer patients. As well as be able to examine situations to help prevent malpractice situations.
Please note, this course is open to all allied health and eye care professionals, such as imagers, technicians, scribes, clinic managers, etc. as an opportunity to gain and develop knowledge. However, due to accreditation restrictions, we cannot provide CE/CME credits to those who are not a licensed OD/DO/MD/RN.
This event gets approved for 4 CME credits through Medical Education Resource and 4 credit hours by the Council on Optometric Practitioner Education (COPE).
Registration will open in November 2020. Please check back for further updates.
Dive into the many manifestations of ocular tumors through diagnosis based on patient history and examination, and diagnostic imaging.
Over the course of an hour, we will dive into the many manifestations of ocular tumors, starting with orbital tumors. Orbital tumors are one of most commonly initially missed ophthalmic diseases seen in clinical practice by Oculoplastic Surgeons. Oculoplastic Surgeon, Dr. Chris Thiagarajah will perform a review of orbital tumors, what to look for, how to diagnose, and key findings. Ocular Oncologist, Dr. Peter Hovland, will then spend the last half of the course presenting an overview of intraocular tumors, exploring eye cancer diagnosis based on patient history and examination, and diagnostic imaging (widefield photography and angiography, ultrasonography, and optical coherence tomography (OCT). By seeking early detection of orbital and intraocular tumors, optometrists and ophthalmologists assist in providing better treatments with lower morbidity and mortality.
PRESENTERS: Peter Hovland, MD, PhD - Ocular Oncologist/Vitreoretinal Specialist at Colorado Retina Associates & Christopher Thiagarajah, MD, FACS - Oculoplastic Surgeon at Park Avenue Oculoplastics
Explore a variety of uveitis manifestations, underlying systemic diseases, presentation patterns & symptoms, the road to proper diagnosis, current treatment options, and the vision-threatening implications uveitis can have for patients.
Uveitis, a general, yet highly complex term for a group of inflammatory diseases with no one size-fits all description, responsible for between 10-15 percent of all cases of blindness in the US. Caused by inflammatory responses, uveitis is not just limited to the uvea, having the potential to wreak havoc throughout the eye and in other parts of the body.
Colorado Retina's uveitis gurus, Dr. Mark Dacey and Dr. Ashleigh Levison, over the course of an hour will explore a variety of uveitis manifestations, underlying systemic diseases, presentation patterns and symptoms, the lengthy road to proper diagnosis, current treatment options, and the vision-threatening implications these diseases can have for patients. Dr. Dacey and Dr. Levison will also cover a few of their most peculiar cases that are not to be missed.
Review of Optical Coherence Tomography (OCT), an emerging technology for performing high-resolution cross-sectional optical imaging. Learn the technical aspects of OCT and potential issues that arise while interpreting data.
Dr. Zak Vest, of MHEI and Dr. Brian Joondeph, of CRA, will provide a brief review of OCT technology, covering the technical aspects of OCT and potential issues that arise while interpreting data. We will dive into OCT output, how to correctly read OCT data findings, signal strength for reliability, and provide education of how to efficiently utilize OCT technology for treatment guidance of glaucoma and diseases of the retina, including AMD and diabetic retinopathy. We will also cover the anatomic measuring capabilities of the current devices in service as well as an overview of their normative database.
Dr. Adam reviewed the many inherited, toxic, and idiopathic maculopathies
Dr. Adam reviewed the many inherited, toxic, and idiopathic maculopathies that can mimic age-related macular degeneration (AMD) in the clinic.
Dr. Hovland wrapped up with content on surgical approaches for retinal detachments. He reviewed the types of retinal detachments there are, issues related to intraocular pressure, and special management of patients with retinal detachments who live at altitude.
Protocols have changed significantly during the COVID-19 pandemic.
Murtaza Adam, MD
Protocols have changed significantly during the COVID-19 pandemic. Which of those procedures are here to stay and which will disappear as the pandemic subsides? NRR host John Kitchens, MD, invites Murtaza “Moo” Adam, MD; David R.P. Almeida, MD, PhD, MBA; and Christina Weng, MD, MBA, to discuss which changes implemented in 2020 will be permanent fixtures in retina practice. Watch the whole discussion back now!
Review of common and uncommon peripheral retinal findings
Review of common and uncommon peripheral retinal findings found on routine funduscopic imaging and exams, including vitreous base pathology, vascular disease, neoplasms, degenerative disease, and variations of normal anatomy. Differential diagnoses, associated findings, and recommendations for management will be covered.